MA MSc PhD FHEA
Liz joined HERC in February 2018, from the Centre for the Advancement of Sustainable Medical Innovation (CASMI) - a policy research group in Oxford’s Radcliffe Department of Medicine. Her work focused on the health economics of cancer drugs, exploring the impact of technology appraisal processes on patient access to drugs, and the value that society places on treating cancer relative to other conditions.
Before joining CASMI, Liz worked as a freelance researcher with clients in pharmaceuticals and education, and as a product development manager in consumer healthcare.
Liz is working with Sarah Wordsworth and colleagues, initially on a series of Discrete Choice Experiments exploring clinician and public attitudes to antibiotics and antimicrobial resistance.
Impact of the COVID-19 Pandemic on Community Antibiotic Prescribing and Stewardship: A Qualitative Interview Study with General Practitioners in England
Borek AJ. et al, (2021), Antibiotics, 10, 1531 - 1531
Impact of the COVID-19 pandemic on community antibiotic prescribing and stewardship: a qualitative interview study with general practitioners in England
BOREK A. et al, (2021), medRxiv
Development of an intervention to support the implementation of evidence-based strategies for optimising antibiotic prescribing in general practice.
Borek AJ. et al, (2021), Implement Sci Commun, 2
What aspects of illness influence public preferences for healthcare priority setting? A discrete choice experiment in the UK
MORRELL E. et al, (2021), PharmacoEconomics
Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom.
Buchanan J. et al, (2021), Appl Health Econ Health Policy